A human model for exploring and understanding resistance to checkpoint inhibitors in cancer. We talk about it with Georgina Long (Co-Medical Director Melanoma Institute Australia, Sidney), that we met at Melanoma Bridge 2019 in Naples.
FONTE: www.oncoinfo.it
